Which of the following treatments is NOT associated with Atrial Fibrillation management?

In the management of Atrial Fibrillation (AFib), treatment strategies focus on controlling the heart rate, restoring normal rhythm, and preventing thromboembolic complications. Amiodarone is an antiarrhythmic medication commonly used to convert AFib to a normal sinus rhythm or to control the heart rate. Adenosine is primarily used for paroxysmal supraventricular tachycardia but can sometimes play a role in managing rapid AFib, particularly when dealing with narrow-complex tachycardia. Heparin is an anticoagulant that helps prevent clot formation in patients with AFib, as they are at increased risk for stroke due to the potential for thrombus formation in the left atrial appendage.

In this context, IV fluids are not directly associated with the specific management of atrial fibrillation. While IV fluids might be administered for various reasons—such as hydration or blood volume support—they do not play a primary role in treating AFib itself. The treatments aimed specifically at managing AFib involve rate or rhythm control and anticoagulation, making IV fluids the least relevant option for this particular condition.